Your browser doesn't support javascript.
loading
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.
Gil-Varea, Elia; Urcelay, Elena; Vilariño-Güell, Carles; Costa, Carme; Midaglia, Luciana; Matesanz, Fuencisla; Rodríguez-Antigüedad, Alfredo; Oksenberg, Jorge; Espino-Paisan, Laura; Dessa Sadovnick, A; Saiz, Albert; Villar, Luisa M; García-Merino, Juan Antonio; Ramió-Torrentà, Lluís; Triviño, Juan Carlos; Quintana, Ester; Robles, René; Sánchez-López, Antonio; Arroyo, Rafael; Alvarez-Cermeño, Jose C; Vidal-Jordana, Angela; Malhotra, Sunny; Fissolo, Nicolas; Montalban, Xavier; Comabella, Manuel.
Afiliação
  • Gil-Varea E; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Urcelay E; Immunology Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria San Carlos (IdISSC), Madrid, Spain.
  • Vilariño-Güell C; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
  • Costa C; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Midaglia L; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Matesanz F; Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina "López Neyra", Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), Granada, Spain.
  • Rodríguez-Antigüedad A; Servicio de Neurología, Hospital Universitario Basurto-Osakidetza, Bilbao, Spain.
  • Oksenberg J; Department of Neurology, University of California, San Francisco, CA, USA.
  • Espino-Paisan L; Immunology Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria San Carlos (IdISSC), Madrid, Spain.
  • Dessa Sadovnick A; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
  • Saiz A; Neurology Service, Hospital Clinic and Institut d'Investigació Biomèdica Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Villar LM; Departments of Immunology and Neurology, Multiple Sclerosis Unit, Hospital Ramon y Cajal, (IRYCIS), Madrid, Spain.
  • García-Merino JA; Neuroimmunology Unit, Puerta de Hierro University Hospital and Research Institute, Universidad Autónoma de Madrid, Madrid, Spain.
  • Ramió-Torrentà L; Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Dr Josep Trueta, IDIBGI, University of Girona, Girona, Spain.
  • Triviño JC; Genomic Systems, Valencia, Spain.
  • Quintana E; Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Dr Josep Trueta, IDIBGI, University of Girona, Girona, Spain.
  • Robles R; Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Dr Josep Trueta, IDIBGI, University of Girona, Girona, Spain.
  • Sánchez-López A; Neuroimmunology Unit, Puerta de Hierro University Hospital and Research Institute, Universidad Autónoma de Madrid, Madrid, Spain.
  • Arroyo R; Servicio de Neurología, Hospital Universitario Quirón Salud, Madrid, Spain.
  • Alvarez-Cermeño JC; Departments of Immunology and Neurology, Multiple Sclerosis Unit, Hospital Ramon y Cajal, (IRYCIS), Madrid, Spain.
  • Vidal-Jordana A; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Malhotra S; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Fissolo N; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Montalban X; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Comabella M; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. manuel.comabella@vhir.org.
J Neuroinflammation ; 15(1): 265, 2018 Sep 14.
Article em En | MEDLINE | ID: mdl-30217166

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Sequenciamento do Exoma / Esclerose Múltipla Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: J Neuroinflammation Assunto da revista: NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Sequenciamento do Exoma / Esclerose Múltipla Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: J Neuroinflammation Assunto da revista: NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha